EGLN1 and osteonecrosis: In this study, we provide evidence from both in vivo and in vitro perspectives to support the role of YGY decoction in counteracting glucocorticoid-induced osteonecrosis oxidative damage through the ROS/PHD2/HIF-1α signaling pathway, aiming to provide more experimental evidence for the clinical application of YGY decoction.